one. 2 So far, five different enzymes dihydropteridine reductase (DHPR), GTP cyclohydrolase I (GTPCH), 6−pyruvoyltetrahy dropterin synthase (PTPS), sepiapterin reductase (SR), and pterin−4a− carbinolamine dehydratase (PCD) have been identified in the synthesis or recycling of BH 4 . 3 Since the newborn screening was carried out in Xinjiang China, more than 200 cases of Uighur patients were diagnosed with PAH deficiency. Recently, we did Sanger sequencing of PAH gene for these patients, but only one did not detect the mutation of PAH.
This child was diagnosed BH 4 deficiency with a QDPR mutation by next-generation sequencing. More interesting, we tracked the family mutation spectrum and found that the 7-year-old sister was PAHdeficient HPA. Therefore, we report on the genotype-phenotype of the child and the pedigree as follows.
| C A S E REP ORT

| Materials and methods
| Patient and clinical data
The criteria of genetic testing were approved by the ethics commit- We present a girl who is 13-month-old. She was born by cesarean section at 36 +2 weeks. Her birthweight was 1600 g.
Amniotic fluid, umbilical cord, and placenta were normal. Apgar scores were 8 at 1 and 5 minutes. She was less active with grunting, tachypnea, and hypotonia after birth. Because of premature birth and tachypnea, she was admitted into the Neonatal Department of People's Hospital of Hotan Prefecture in Xinjiang.
Blood glucose was only 0.1 mmol/L (2.2-7.0 mmol/L) after admission. Admission diagnoses were aspiration of amniotic fluid syndrome, premature infant, and low birthweight infant. She recovered and was discharged from hospital. Neonatal screening was carried out until 3 months after birth, and the value of blood Phe concentration was 6.2 mg/dL. The parents did not pay attention to the disease, the child was only re-collected dried blood spots (DBSs) at 13 months, and the value of Phe concentration was 13.41 mg/dL. Physical examination showed she had white skin and yellow hair without rat urine smell. The girl had attention deficit and she was floppy. Her blood glucose, blood cell count, and electrolytes were all normal. Head Computed Tomography (CT) showed white matter dysplasia and have a deep brain sulcus. Her parents refused other auxiliary examinations. She was the fourth child of nonconsanguineous parents of Uygur ethnicity. She has 2 older brothers and 1 older sister. The two brothers did not have the symptoms which were associated with phenylketonuria and were able to study and live normally.
Her older sister also had mental retardation and was not able to walk until 7 years old. We collected the blood sample for Phe detection from her sister, and the value of Phe in the DBSs was 18 mg/dL.
| Biochemistry test for differential diagnosis
The dried blood spots (DBSs) and urine sample of the patient were sent to institute of Xin Hua Hospital of Shanghai for tandem mass spectrometry, urinary pterin analysis, and determination of DHPR activity. For economic reasons, the older sister only performed tandem mass spectrometry.
| Genetic test and mutation analysis
All specimens were sequenced from 13 exons of PAH gene. If the result of sequencing was negative or only a single heterozygous mutation was found, the next-generation sequencing was performed.
Then, we will validate it by Sanger sequencing if the results are positive.
DNA isolation
We collected the peripheral venous blood about 2 mL of the patient, the older sister and their parents. DNA isolation was performed using the QIAamp DNA Blood Mini Kit (250) (QIAGEN, Vienna, Austria).
Polymerase chain reaction condition and Sanger sequencing
PCR primers were designed to amplify all 13 exons and the sur- 
Next-generation sequencing
Exome capture was accomplished using the TruSeq™ Exome Enrichment Kit (Illumina) and sequencing was performed using the Illumina Hiseq 2500 platform following the manufacturer's protocol.
It covers a minimum of 98% of the genome with 20× coverage and is compared to a human reference sequence.
Data analysis
Variants were annotated using Variant Effect Predictor (VEPEnsembl 73). Functional exonic and splicing variants were considered in the analysis. This contains loss of function (stop, frameshift, and splice) or missense (nonsynonymous and nonframeshift) mutations, these mutations are predicted to have high and moderate impact, respectively. The three major databases for known pathogenic and likely pathogenic mutations were used including ClinVar, OMIM, and HGMD Professional. Numerous missense functional predictors, noncoding regulatory region annotations, and others were included. To be able to filter out variants of high frequency, the allelic frequencies were annotated from the public datasets from the 1000 Genomes, the Exome Sequencing Project 
| Result
| Biochemistry test
The tandem mass spectrometry results of the patient showed 
| Gene mutation analysis
Sanger sequencing of PAH gene in this patient was negative, but her sister was detected 2 heterozygous mutation c. Pedigree mutation sites and mutation analysis of the family are shown in Figure 3 and Table 1 .
| D ISCUSS I ON
Hyperphenylalaninemia (HPA) is caused by phenylalanine hydroxylase deficiency (PAHD) (98%) or BH 4 deficiency (2%). 4 Internationally, PTPS deficiency is a major subset of cause (accounts F I G U R E 3 Segregation analysis of QDPR gene mutations and pedigree of the family examined in the present for 65%), followed by DHPR deficiency (accounts for 25%). 5 GTPCH and PCD deficiencies are relatively uncommon, each accounting for approximately 4%. 6 In the mainland of China, PTPS deficiency accounts for 96% and DHPR deficiency only accounts for 2.4%, so the incidence of DHPR in China was very low. 7, 8 In 1975, the first case of DHPR deficiency was reported by Butler. 9 Early treatment can greatly improve the prognosis.
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In this case of DHPR deficiency, white skin, hypotonia, serious nervous system dysfunction and other clinical manifestations are similar to previous reports of clinical manifestations of BH 4 deficiency. In the differential diagnosis, the blood Phe concentration was slightly elevated; urinary pterin analysis showed no significant abnormalities; DHPR activity was 31.11% of the normal enzyme activity. Lu et al previously reported DHPR activity decreased significantly-the lowest enzyme activity decreased to 3.13% of normal activity, up to normal activity of 13.67%. 12 Therefore, the DHPR enzyme activity of our case was not significantly reduced. Considering the enzyme activity test results are affected by many factors, the patient was diagnosed as DHPR deficiency until received the genetic testing. So the definite diagnosis depends on genetic testing.
The next-generation sequencing detected a homozygous mutation in the QDPR gene c.508G>A (p.G170S) in this child. The mutation was previously reported as a pathogenic mutation. In vitro experiments presumed that it could produce abnormal enzyme structure, increasing by four times the Km for NADH compared to the wild-type enzyme, and reduced DHPR mRNA expression. 
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